News from the FDA/CDC
News from the FDA/CDC
FDA OKs low-dose colchicine for broad CV indication
“The FDA approval of colchicine for patients with atherosclerotic disease is a huge signal that physicians need to be aware of inflammation as a...
News from the FDA/CDC
FDA class 1 recall for some Abiomed Impella heart pumps
“If a purge leak occurs, the system will experience low purge pressures, prompting alarms and requiring evaluation.”
News from the FDA/CDC
FDA OKs Injectafer for iron deficiency anemia in heart failure
“This new indication for Injectafer marks the first and only FDA approval of an intravenous iron replacement therapy for adult patients with heart...
News from the FDA/CDC
FDA approves new drug, sotagliflozin, for heart failure
“It will be a reasonably tall task for sotagliflozin to come from behind and be disruptive in a space where there are already two well-established...
News from the FDA/CDC
FDA expands use of dapagliflozin to broader range of HF
The sodium-glucose cotransporter 2 inhibitor was previously approved in the United States for adults with heart failure with reduced ejection...
News from the FDA/CDC
FDA approves first RSV vaccine for older adults
Older adults with underlying health conditions, such as lung or heart disease, are at high risk for severe disease.
News from the FDA/CDC
CDC gives final approval to Omicron COVID-19 vaccine boosters
“If you are eligible, there is no bad time to get your COVID-19 booster,” said CDC Director Rochelle Walensky, MD.
News from the FDA/CDC
COVID to blame as U.S. life expectancy falls
The overall drop took national life expectancy from 78.8 years in 2019 to 77 years in 2020.
News from the FDA/CDC
Long COVID doubles risk of some serious outcomes in children, teens
“Many of these conditions were rare or uncommon among children in this analysis, but even a small increase in these conditions is notable.”
News from the FDA/CDC
FDA grants emergency authorization for Novavax COVID vaccine
Clinical trials found the vaccine to be 90.4% effective in preventing mild, moderate or severe COVID-19.
News from the FDA/CDC
FDA orders Juul to stop selling E-cigarettes
The marketing denial order covers only the commercial distribution and retail sale of Juul’s products and doesn’t restrict consumer possession or...